Bionow awards under the wing of Concorde
About Richard Maclennan: I’m Richard, before joining Appleyard Lees and training as a patent attorney I worked as a senior research scientist/study director on an EU research project. My role involved managing a number of different projects and experiments that were continuously producing data that needed to be reported to various stakeholders across Europe. From the first day working in my previous job I […]
‘Pitch in a Pub’- in person!
About Richard Maclennan: I’m Richard, before joining Appleyard Lees and training as a patent attorney I worked as a senior research scientist/study director on an EU research project. My role involved managing a number of different projects and experiments that were continuously producing data that needed to be reported to various stakeholders across Europe. From the first day working in my previous job I […]
Protecting IP in lab-grown organs – organoids
Lab-grown miniature organs (also known as organoids) is a technology area that has the potential to significantly lower costs and failure rates in drug development, and to improve safety.
Responsibilities as a trainee patent attorney
About Richard Maclennan: I’m Richard, before joining Appleyard Lees and training as a patent attorney I worked as a senior research scientist/study director on an EU research project. My role involved managing a number of different projects and experiments that were continuously producing data that needed to be reported to various stakeholders across Europe. From the first day working in my previous job I […]
Networking at the virtual Bionow awards dinner
highlight of the networking year for a life science trainee patent attorney based in Manchester is the Bionow awards dinner usually held in December. “Networking” may not be that fun for many trainee patent attorneys (or qualified attorneys for that matter) but think of it as an opportunity to get out of the office and meet people.
Reduced patent fees for businesses qualifying as small or micro entities – a discussion of requirements, benefits and risk in Canada, Japan and the U.S.
Pursuing patent protection in multiple countries can be expensive. Whilst cost is always important, for some small companies, reducing expenditure is currently paramount to survival during the enforced global slowdown.
